Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
4.745
-0.255 (-5.10%)
At close: Apr 1, 2025, 4:00 PM
4.750
+0.005 (0.11%)
After-hours: Apr 1, 2025, 4:42 PM EDT
Altimmune Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Altimmune stock have an average target of 21, with a low estimate of 12 and a high estimate of 26. The average target predicts an increase of 342.57% from the current stock price of 4.75.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Altimmune stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 4 | 4 | 4 | 4 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 7 | 7 | 8 | 8 | 8 | 8 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +152.90% | Mar 18, 2025 |
Citizens Capital Markets | Citizens Capital Markets | Buy Reiterates $25 | Buy | Reiterates | $25 | +426.87% | Mar 14, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +152.90% | Mar 3, 2025 |
William Blair | William Blair | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Feb 28, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +152.90% | Feb 5, 2025 |
Financial Forecast
Revenue This Year
n/a
from 20.00K
Revenue Next Year
n/a
EPS This Year
-1.52
from -1.34
EPS Next Year
-1.72
from -1.52
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | 135.1M | ||
Avg | n/a | n/a | 32.9M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -1.30 | -1.30 | -0.65 | ||
Avg | -1.52 | -1.72 | -1.46 | ||
Low | -1.84 | -2.09 | -2.12 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.